SRS Capital Advisors Inc. Acquires 358 Shares of Aflac Incorporated (NYSE:AFL)

SRS Capital Advisors Inc. raised its holdings in shares of Aflac Incorporated (NYSE:AFL) by 351.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 460 shares of the financial services provider’s stock after buying an additional 358 shares during the quarter. SRS Capital Advisors Inc.’s holdings in Aflac were worth $48,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Franklin Resources Inc. lifted its position in Aflac by 75.2% during the third quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock valued at $88,533,000 after purchasing an additional 333,083 shares during the last quarter. Aptus Capital Advisors LLC raised its stake in shares of Aflac by 79.7% in the third quarter. Aptus Capital Advisors LLC now owns 27,354 shares of the financial services provider’s stock valued at $3,058,000 after acquiring an additional 12,131 shares during the period. Transamerica Financial Advisors Inc. purchased a new stake in shares of Aflac in the third quarter valued at $979,000. Roxbury Financial LLC purchased a new stake in shares of Aflac in the fourth quarter valued at $948,000. Finally, FMR LLC raised its stake in shares of Aflac by 4.0% in the third quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock valued at $134,395,000 after acquiring an additional 45,745 shares during the period. Institutional investors own 67.44% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AFL. Wells Fargo & Company reduced their target price on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 19th. Morgan Stanley increased their target price on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Piper Sandler reduced their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research note on Friday, February 7th. Evercore ISI reduced their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. Finally, JPMorgan Chase & Co. increased their target price on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $103.36.

Aflac Stock Up 0.5 %

Shares of Aflac stock opened at $108.48 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a 1 year low of $79.31 and a 1 year high of $115.50. The firm’s 50-day moving average is $105.08 and its two-hundred day moving average is $107.70. The stock has a market cap of $59.29 billion, a price-to-earnings ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.